A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis–infected Adults

Rationale: Novel tuberculosis (TB) vaccines should be safe and effective in populations infected with Mycobacterium tuberculosis (M.tb) and/or HIV for effective TB control. Objective: To determine the safety and immunogenicity of MVA85A, a novel TB vaccine, among M.tb- and/or HIV-infected persons in...

Full description

Saved in:
Bibliographic Details
Main Authors: Scriba, Thomas J., Tameris, Michele, Smit, Erica, van der Merwe, Linda, Hughes, E. Jane, Kadira, Blessing, Mauff, Katya, Moyo, Sizulu, Brittain, Nathaniel, Lawrie, Alison, Mulenga, Humphrey, de Kock, Marwou, Makhethe, Lebohang, Janse van Rensburg, Esme, Gelderbloem, Sebastian, Veldsman, Ashley, Hatherill, Mark, Geldenhuys, Hendrik, Hill, Adrian V. S., Hawkridge, Anthony, Hussey, Gregory D., Hanekom, Willem A., McShane, Helen, Mahomed, Hassan
Format: Artigo
Language:Inglês
Published: American Thoracic Society 2012
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3326425/
https://ncbi.nlm.nih.gov/pubmed/22281831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201108-1548OC
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items